Skip to content

Verbal Analgesia Versus Standard Care for Pain Control in Women With Primary Infertility Undergoing Office Hysteroscopy

Verbal Analgesia Versus Standard Care for Pain Control in Women With Primary Infertility Undergoing Vaginoscopic Office Hysteroscopy: A Randomized Controlled Trial

Status
Recruiting
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT07325994
Enrollment
92
Registered
2026-01-08
Start date
2025-10-20
Completion date
2026-03-15
Last updated
2026-01-08

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Hysteroscopy

Brief summary

Office hysteroscopy is a cornerstone in the diagnostic evaluation of infertile women, enabling direct visualization of the uterine cavity for identifying intrauterine pathology. The vaginoscopic (no-touch) approach, which eliminates the use of a speculum and tenaculum, is increasingly adopted due to improved tolerability, higher success rates, and reduced pain compared to conventional methods.

Detailed description

Office hysteroscopy is a cornerstone in the diagnostic evaluation of infertile women, enabling direct visualization of the uterine cavity for identifying intrauterine pathology. The vaginoscopic (no-touch) approach, which eliminates the use of a speculum and tenaculum, is increasingly adopted due to improved tolerability, higher success rates, and reduced pain compared to conventional methods. Despite this, many women still report moderate to severe pain, particularly during cervical passage and uterine distension. High pain scores may result in incomplete examinations, decreased patient satisfaction, and increased need for sedation or analgesia. Various pharmacological interventions have been studied, including NSAIDs, local anesthetics, and misoprostol, with inconsistent or limited benefit. Verbal analgesia, a structured communication strategy involving calm, supportive, and reassuring verbal cues, has been shown to reduce procedural pain in other gynecologic settings such as IUD insertion. However, no randomized trial has specifically evaluated structured verbal analgesia in women with primary infertility undergoing vaginoscopic office hysteroscopy. This trial aims to address this evidence gap by comparing verbal analgesia with standard neutral communication, with both groups receiving baseline NSAID premedication.

Interventions

Providers will deliver a standardized verbal analgesia script in a calm, slow-paced, supportive tone, synchronized to procedural steps: * Scope introduction (introitus → external os): You may feel light pressure as the camera enters-keep a slow, steady breath; you are doing well. * Cervical passage (internal os): A brief pinch or cramp may happen now; it will pass quickly-breathe in slowly, and out. * Uterine entry and distension: A feeling of fullness is expected; stay with your breath-it eases in moments. * Cavity inspection: You may notice short waves of cramp; they are normal and brief-you're managing this well. * Withdrawal: We are nearly finished-slow exhale as we come out. That's it, you did great. Providers will undergo training to ensure fidelity. All participants will receive ibuprofen 600 mg orally one hour before hysteroscopy as standard analgesia.

BEHAVIORALstandard care

Providers will use neutral, procedural statements without supportive phrasing, e.g., Starting the camera now, Passing the cervix, Entering the uterus, Inspecting the cavity, Withdrawing the camera.. All participants will receive ibuprofen 600 mg orally one hour before hysteroscopy as standard analgesia.

Sponsors

Aljazeera Hospital
CollaboratorOTHER
Cairo University
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
PREVENTION
Masking
NONE

Eligibility

Sex/Gender
FEMALE
Age
18 Years to 40 Years
Healthy volunteers
No

Inclusion criteria

* o Women aged 18-40 years. * Diagnosis of primary infertility (failure to conceive after ≥12 months of unprotected intercourse). * Indication for diagnostic office hysteroscopy. * Regular menstrual cycles.

Exclusion criteria

* o Secondary infertility. * Known pelvic infection, cervicitis, or vaginitis. * Use of analgesics within 8 hours prior to procedure. * Cervical stenosis, prior failed hysteroscopy, or known uterine anomaly. * Contraindication to NSAIDs * Pregnancy or suspected pregnancy.

Design outcomes

Primary

MeasureTime frameDescription
pain during OHDuring the procedure (immediately after insertion of hysteroscope, assessed within 5 minutesIt will be measured by 0-10 numerical rating scale where 0 indicates no pain and 10 worst pain imaginable

Secondary

MeasureTime frameDescription
Patient satisfactionAt the end of the visit (within 30 minutes of procedure completion)Patient satisfaction on a 0-10 NRS (0 = no satisfaction, 10 = maximum satisfaction).

Countries

Egypt

Contacts

Primary ContactMahmoud alalfy
mahmoudalalfy@ymail.com+201002611058

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026